Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study of Vadadustat in Hemodialysis Participants With Anemia Switching From Epoetin Alfa

ClinicalTrials.gov ID: NCT03799627

Public ClinicalTrials.gov record NCT03799627. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 5:54 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 2, Randomized, Open-Label, Active-Controlled, Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics Study of Oral Vadadustat for the Treatment of Anemia in Hemodialysis Subjects Converting From Epoetin Alfa (FO2RWARD-2)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase 2 open-label efficacy, safety, and pharmacokinetic/pharmacodynamic (PK/PD) study to evaluate oral Vadadustat for the treatment of anemia in hemodialysis participants converting from Epoetin Alfa therapy.

Study identification

NCT ID
NCT03799627
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Akebia Therapeutics
Industry
Enrollment
175 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 99 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2019 (Actual)
Primary completion
Jun 5, 2020 (Actual)
Completion
Jul 15, 2020 (Actual)
Last update posted
Sep 29, 2022

2019 – 2020

United States locations

U.S. sites
41
U.S. states
16
U.S. cities
35
Facility City State ZIP Site status
Research Site Fresno California 93720 —
Research Site Granada Hills California 91344 —
Research Site Los Angeles California 90022 —
Research Site Northridge California 91324 —
Research Site Riverside California 92501 —
Research Site #1 San Dimas California 91773 —
Research Site #2 San Dimas California 91773 —
Research Site San Gabriel California 91776 —
Research Site Tarzana California 91356 —
Research Site Vacaville California 95688 —
Research Site Victorville California 92394 —
Research Site Denver Colorado 80230 —
Research Site Bridgeport Connecticut 06606 —
Research Site Hartford Connecticut 06762 —
Research Site Coral Gables Florida 33134 —
Research Site Hollywood Florida 33024 —
Research Site Miami Florida 33126 —
Research Site Miami Florida 33134 —
Research Site Miami Florida 33150 —
Research Site Tampa Florida 33607 —
Research Site Tampa Florida 33614 —
Research Site Winter Park Florida 32789 —
Research Site Augusta Georgia 30909 —
Research Site Statesboro Georgia 30458 —
Research Site Roseville Michigan 48066 —
Research Site #1 Minneapolis Minnesota 55404 —
Research Site #2 Minneapolis Minnesota 55404 —
Research Site Kansas City Missouri 64111 —
Research Site Las Vegas Nevada 89107 —
Research Site The Bronx New York 10461 —
Research Site Asheville North Carolina 28801 —
Research Site Wilmington North Carolina 28401 —
Research Site Canton Ohio 44718 —
Research Site Oklahoma City Oklahoma 73116 —
Research Site El Paso Texas 79915 —
Research Site Houston Texas 77004 —
Research Site San Antonio Texas 78229 —
Research Site San Antonio Texas 78258 —
Research Site Chesapeake Virginia 23320 —
Research Site Norfolk Virginia 23510 —
Research Site Wauwatosa Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03799627, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 29, 2022 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03799627 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →